™E Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders By Investing.com
BERLIN--( BUSINESS WIRE )-- Regulatory News:
E Pharma NV™ (Euronext Growth Paris: AL™E) (Paris: AL™E), The biotechnology company, which is focused on developing novel therapies to treat cancer by targeting the tumor microenvironment…